Shaping Peptides, Driving Innovation and Progress in Biotechnology

Peptide Discovery & Develop Platform

Peptide-based technologies are revolutionizing various fields, significantly impacting both productivity and therapeutic applications. These technologies involve the design, synthesis, and application of peptides, which are short chains of amino acids. Their versatility and specificity make them powerful tools in modern medicine and biotechnology.  

  • Drug Discovery and Development: Peptides are accelerating drug development by offering targeted therapies with high specificity and low toxicity. Artificial intelligence (AI) and machine learning are further enhancing this process, reducing costs and improving efficiency in identifying and designing novel peptides.  

  • Biomaterial Development: Peptides are used to enhance the functionality of medical implants and create biocompatible materials for tissue engineering and regenerative medicine.

  • Industrial Biotechnology: Peptides play a role in various industrial processes, including enzyme production and biocatalysis.  

Pipeline

Completely novel molecules for specific functional use in therapies & for productive purpose

 

Experimentation/ Discover. Pep Design & Synthesis. Characterization & Quality control. In vitro/ in vivo testing Pre Clinical/ Clinical trials

Leo.pep_0.1

Leo.pep_0.2

Leo.pep_0.1 peptides for aquaculture industry

  • These peptides could reduce the transition times from freshwater to seawater and lagging phenotypes.

  • Strengthening the immune system, increasing resistance against bacterias and viruses, reducing the use of antibiotics.

  • They are low-cost to produce and they are stable, enabling large-scale production to meet industry demand.

  • High potential to develop different pharmaceutical forms and administrations: with development they can be adapted to be administered orally, reducing the costs associated with application via injection.

Completely novel molecules for groundbreaking applications within the industry, and patent applications are in progress.

Recognizing the complexities of innovation and new technology development, we champion a collaborative approach to achieve significant results and impact. Our strategy is strengthened by key partnerships: access to cutting-edge scientific equipment through the MELISA Institute's core facility (featuring advanced proteomics and genomics capabilities), robust intellectual property protection with Santa Cruz IP, and our recent inclusion in the CHILEMASS Programe, fostering vital connections between Chilean and Massachusetts businesses.

Our CTO, Mauricio Hernandes, further enhances our scientific network through strong collaborations with leading researchers at the University of Concepción, Universidad Andrés Bello, Vienna University, and Vanderbilt University in proteomics, immunology, and flow cytometry.

Scientific infrastructure and collaborations

Team & Founders

  • Mauricio Hernandez

    Co Founder & CSO

    Biochemist ,MSc Microbiology , PhD(c) Clinical Applied Sc. Proteomics Specialist.

    Vanderbilt University, Universidad Austral, Universidad de Concepción.

    +100 Peptides designed. Senior experience in research, biotech innovations and scientific publications.

  • Patricio Pizarro

    Co Founder & Financial Lead

    Commercial Engineer,Private Equity Graduate.

    University of Oxford, Universidad Austral.

    +15 years of experience in tech transfer and early stage investment. 

    4X founder, 2 Startup investor and board member in Biotech and Data Analytics sector.

  • Cristian Placencia

    Co Founder

    Pharmacist, MBA.

    Universidad del Desarrollo, Universidad de Concepción.

    2X Pharmaceutical company General Manager.

    Senior experience industry in general management, sales, commercials and growth strategy.

  • Jorge Becar

    Co Founder & Legal Lead.

    Lawyer, Master of Laws

    Universidad de Concepción, Edinburgh University.

    Partner in Becar & Becar Law Office. Senior experience in Intellectual Property, Taxes, International Trade and Investment.

  • Felipe Reyes

    Co Founder

    Pharmacist, MBA, MHA

    Universidad Austral, Universidad Católica, Universidad del Desarrollo

    Senior experience as manager in the pharmaceutical industry in marketing, business development and market access.

Contact US